Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: a Phase I Study

PURPOSE: We designed a new regimen by combining intraperitoneal (IP) paclitaxel (PTX) with systemic S-1 plus oxaliplatin (SOX) for the treatment of advanced gastric cancer with peritoneal metastasis. This dose-escalation study aimed to determine the maximum tolerated dose (MTD) and recommended dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Wook, Seo, Won Jun, Youn, Sang Il, Jee, Ye Seob, Jang, You-Jin, Kim, Jong-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753277/
https://www.ncbi.nlm.nih.gov/pubmed/35079443
http://dx.doi.org/10.5230/jgc.2021.21.e38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753277/
https://www.ncbi.nlm.nih.gov/pubmed/35079443
http://dx.doi.org/10.5230/jgc.2021.21.e38

Ejemplares similares